Skip to main content
. 2008 Sep 26;112(13):4953–4960. doi: 10.1182/blood-2008-06-163048

Table 1.

Immunohistochemical analysis of metastatic melanoma lesions

Cell counts per 10 high-power field
Intratumoral lymphocytes
Peritumoral lymphocytes
Responders (n = 11) Nonresponders (n = 9) Responders (n = 11) Nonresponders (n = 9)
CD4+, total ± SEM 142 ± 39 75 ± 18 587 ± 153 475 ± 69
FOXP3+ CD4+, total ± SEM 33 ± 8 26 ± 8 101 ± 28 90 ± 16
FOXP3+/CD4+, % ± SEM 24 ± 4 30 ± 6 17 ± 2 19 ± 2
CD8+, total ± SEM 263 ± 53 170 ± 54 476 ± 89 448 ± 79
FOXP3+ CD8+, total ± SEM 0.6 ± 0.2 0.6 ± 0.3 1.4 ± 0.9 2.3 ± 0.7
FOXP3+/CD8+, % ± SEM 0.2 ± 0.1 0.3 ± 0.2 0.2 ± 0.1 0.4 ± 0.1